A genetically modified cell that expresses a TGFβ inhibitor and is a lung cancer cell

• 收藏
• 分享

专利权人:

ノヴァークス

发明人:

ファクライ，ハビブ,ファクライ,ハビブ

申请号：

JP2001572145

公开号：

JP5079962B2

申请日:

2001.03.30

申请国别(地区):

JP

年份:

2012

代理人:

摘要：

The present invention relates to compositions comprising a therapeutically effective amount of genetically modified cells containing a genetic constructs expressing a TGF² inhibitor effective to reduce expression of TGF², where the genetically modified cells are non-small cell lung cancer (NSCLC) cells or small cell lung cancer (SCLC) cells, and related methods.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/